Professional services firms moved AI-assisted delivery from pilot to production between 2024 and 2026. This paper takes up five questions that follow. What does a firm sell once clients can license the same models? Who answers for an error that passes through five agents? Does a validator role build judgment, or only train the next model? What separates a governed AI deliverable from one that fails its own citations? And what can a new hire expect three years out? The paper treats commercial model, operating design, and behavioral incentives as one design problem. Its main mechanisms are an Emergency Override Protocol that makes declaring a suspension cheaper than hiding one; a paired metric that pays partners for keeping human capability only when delivery efficiency also holds; a rotating Challenger role grounded in vigilance research; an experience-portfolio talent model built around two to three years of tenure and an alumni network; and a two-tier operating model for data-residency regimes, with Saudi Arabia as the worked case. The paper argues that the firm's lasting advantages are its independence from the client's frame, accountability that a regulator can reach, and a data feedback loop competitors cannot buy. Working paper, not peer reviewed. The views expressed in this paper are the author's own and do not represent the position of his employer or any of its member firms.
No takes yet. Share an insight, caveat, or question.
Andrey Ivanov (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: